chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case reported by a consumer, describes the occurrence of ageusia (I received my second Moderna vaccine in April, since then I have lost my sense of taste. Have you had this reported before?) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. April 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. April 2021, patient had ageusia (I received my second Moderna vaccine in April, since then I have lost my sense of taste. Have you had this reported before?). At the time of the report, ageusia (I received my second Moderna vaccine in April, since then I have lost my sense of taste. Have you had this reported before?) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information provided.
Woke up extremely hot, nauseaus. At 0410 I felt like I had to have a bowel movement, sat on toilet for awhile, projectile diarrhea began. Then vomiting.  Same symptoms I had with Covid in June. extremely tired for about a week. Called my son who works for Pfizer the next day (the 4th of February).  I want to reschedule my second vaccine for later in March because my Endocrinologist has put in a referral to have my antibodies tested.  Unfortunately I just had a tooth extracted and am on antibiotics, not sure if that will affect the antibody test or the second vaccine.
left-sided facial paralysis, dry eyes, and eye irritation from not being able to close eyes; speech difficulty
no additional adverse events; a 2 month old patient was administered PNEUMOVAX 23 instead of PREVNAR 13; a 2 month old patient was administered PNEUMOVAX 23 instead of PREVNAR 13; This spontaneous report was received from a registered nurse and refers to a 2-month-old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided.  On 19-NOV-2019, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot # S026366, expiration date 17-SEP-2020 (vaccination site and route of administration were not reported) for prophylaxis. The pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was administered instead of pneumococcal 13v conj vaccine (CRM197) (PREVNAR 13). This was not a product confusion. No additional adverse events were reported.  The outcome was not reported.
Expired Engerix-B administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 39-year-old female patient who received HBV (Engerix B) (batch number T2S4Z, expiry date 20th November 2022) for prophylaxis.   On 27th December 2022, the patient received the 3rd dose of Engerix B. On 27th December 2022, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 29-Dec-2022 Reporter's comment: The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up via email. Additional supportive information: The patient received an expired dose of Engerix-B, which led to expired vaccine used.
experiencing a cycle but has been menopausal; tinnitus in left ear; tingly feeling in arm, hands and back / feels like body parts are on pins and needles; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of POSTMENOPAUSAL HAEMORRHAGE (experiencing a cycle but has been menopausal) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history for the patient was reported.  Concomitant products included SPIRONOLACTONE and ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION) for an unknown indication.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced POSTMENOPAUSAL HAEMORRHAGE (experiencing a cycle but has been menopausal) (seriousness criterion medically significant), TINNITUS (tinnitus in left ear) and PARAESTHESIA (tingly feeling in arm, hands and back / feels like body parts are on pins and needles). At the time of the report, POSTMENOPAUSAL HAEMORRHAGE (experiencing a cycle but has been menopausal), TINNITUS (tinnitus in left ear) and PARAESTHESIA (tingly feeling in arm, hands and back / feels like body parts are on pins and needles) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history was provided by the reporter.   Treatment information was not provided.  Company comment: Very limited information regarding the events has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
5/10/21 fever 101 degrees 5/11/21 fever 100.5 degrees 5/12/21 fever 100 degrees 5/13/21 fever 99.5 degrees 6/9/21 I had shoulder surgery. (Right SLAP repair) 6/20/21 I was diagnosed with 3 blood clots in my right upper arm. 1 superficial thrombophlebitis of the basilic vein. 2 DVTs of the brachial and axillary vein.
Tinnitus,  mostly in left ear. Can be severe. Disrupting sleep and ability to fall asleep. Started April 1.  Is there 24 hours a day.
Adverse event: PT here for first dose of Pfizer COVID vaccine. PT reported feeling anxiety before vaccination, but indicated that she was ready for her vaccination. Immediately post-vaccination, PT experienced an apparent vasovagal response, presenting with palor, slumped posture. PT's eyes were open, but PT was unresponsive and later reported no memory of events. PT became responsive within 2 minutes, but remained "shakey" and pale. RN was in attendance and provided initial assessment/response. RN also responded to PT. Aid was called at 1251 and EMTs arrived at 1253. Aid assessed PT, took vital signs (1256: BP 104/56 laying, HR 70, SPO2 98% on room air, 1303 BP 110/62 laying, HR 87, SPO2 99% RA, 1307: BP 96/58 sitting, SPO2 99%RA, 1311: BP 106/62 sitting, SPO2 99% RA).  Treatment: PT was assisted to lay down on cot, water and juice were provided and consumed, cool compress were provided. Psychosocial support provided. Education to PT and mother to monitor for further s/s and to seek out urgent care if more were noted.  Outcome: PT's color improved soon after laying down, PT reported "feeling better" after consuming juice and water. PT sat at edge of cot without difficulty, walked down hallway without difficulty. PT medically cleared by EMS at 1223, exited facility with mother in private vehicle.
Rash in certain spots around my body, that are red and painful to the touch just like the shot area pain and redness, the spots that are red hurts a lot.
Positive pregnancy test, followed by constipation, nausea, bloating, lower back pain (continuing until now)
Upon 10 or so minutes post injection: Pain muscular at injection site, expected this.  Pain down right side of arm Hot, swetting Nausea Numbness full body *Wet wash cloth received for forehead. Numbness hands fingers toes tongue Cold and chills  *Received Benadryl  Ambulance to ED: Blood pressure spike  Shaking  Right jaw pain Now zero left pain   At ED: Vitals okay  *Received Pepcid and  Something under the tongue for nausea  Dry mouth Dry throat  Toes return to normal  Right jaw and neck and head pain *Practiced self-prompted jaw exercises.  Still very cold. Less shaking, more intermittent like waves  Tongue and roof of mouth tingly Right quad pain  *Received Blanket and now warm  No headache pain.  Right injection site muscular pain.   Discharged from hospital
Received vaccination on 7/13/07, per mother. Fevers on 7/12/07 and 7/14/07. Mother described blood in stool on 7/13/07.  7/27/07 Received hospital medical records which reveal patient experienced fever, bloody stools & been transferred from outlying ER.  Admitted 7/14-7/17/07.   FINAL DX: R/O sepsis & bloody stool secondary to rotateq vaccine. 8/3/07 Received vax records which provide RO lot & dose #1.  VAERS database updated w/additional vax info.
pt recv vax & devel an inj site rxn characterized by an area of redness & itching measuring 3 inches in diameter;pt recovered;
Pt found to be COVID positive on pre-surgical testing for a left femoral neck fracture.  Pt had received his COVID booster on 10/5/2021.
Patient contracted COVID after being fully vaccinated; no booster. Headache, fever, chills, congestion, runny nose, cough, fatigue.
Excessive, pronounced exhaustion.  Body aches, chills & strong headache throughout the night.  Went to bed at 10:00pm 11/8/21 & did not wake until 10:30am on 11/9/21.  Strong pain in entire upper left arm, painful to move around in bed. Ate 3 very healthy meals on 11/8/21 & hydrated with water throughout the day & night.  Took (1) Extra Strength Tylenol @ 11:30am on 11/9/21 to relieve the headache. I remain quite foggy & lethargic. I did not experience any of these markedly elevated side affects with either of my first 2 Pfizer shots.
About 10 hours after dose 2, full onset of symptoms including - chills, hot/cold, flu-like symptoms, extreme shaking, dizziness, nausea, diarrhea, fever, inability to stand, exhaustion, heart racing (watch indicated 135 beats per minute), parched, headache, extreme radiating pain in head, neck, shoulders, pain in toes and ankles, muscle aches
54yr old male who presents ambulatory with spouse to ED with complaints of left lower buttocks sore. Patient noticed this lump this last Wednesday, and since then it has continued to grow in size. Patient was seen in urgent care yesterday, where they prescribed him with antibiotics. Patient has had a total of three doses. Patient rates pain 8/10. Patient's spouse stated he had a fever yesterday, but it has subsided at this time. Patient is diaphoretic and hot upon arrival. Patient has taken tylenol last at 1100 today. Perineal abscess Acute This was a fairly deep abscess cavity (~10 cm) that did track up next to the rectum.   We felt that some of this might represent sepsis, ForDIAGNOSIS 1. Fever, unspecified    2. Sinus tachycardia    3. Leukocytosis, unspecified type    4. AKI (acute kidney injury)   5. Hyponatremia    6. Perineal abscess   Principal Problem:   Sepsis Active Problems:   Type 1 diabetes mellitus with complications   Diabetic polyneuropathy associated with type 1 diabetes mellitus   Anxiety   Perineal abscess   Plan:  1) Sepsis/ Bacteremia suspected - IV Zosyn   2) Perineal abscess - S/p I&D.  Wound care with packing   3) Type 1 DM - Continue home Insulin pump.  Add accuchecks   4) AKI - IV fluids.  Follow  ED then hospitalized for 2 days
patient stopped in the pharmacy today (9/7) and showed me areas of her elbows and along her lower back and thigh where she had welting occur. She reported this began last night (0/6). I instructed her to take Benadryl 25 mg, ii q 6 h until resolved. I called her 4 hours later and she said she was drowsy and the welting was dissipating.
tingling down my left arm into my hand within an hour of the vaccine  inflammatory arthritis sets into both hands & wrists within the next two weeks the inflammation continues to travels down to my knees, ankles, and feet
pt stated lt arm had small bruise @ site where inject was given; lt arm red & swollen about 2 inches wide by 5 inches long;
approx 1hr p/vax pt became very flushed from face to mid chest;cheeks were the most affected & also had small hives;no itching, some facial tingling;nurse had left when sx began;
Pt received flu vaccination to the L thigh on 11/13. Noticed blisters on the L thigh yesterday, 11/15. Today, seems to be worse. Erythematous edematous plaque on L thigh with overlying intact vesicles and bullae, erosion within.
Information regarding Flumist (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen)) was received from a nurse regarding a 33-year-old female patient who experienced fever of 103 F., her body ached and nasal congestion. At 33 years of age, the patient received a dose on 12-Dec-2003. Medical History: Relevant medical history was not provided. Product Details: Indication for Flumist (2003-2004 Formula) was immunization. Product was administered on 12-Dec-2003. Dose regimen was 1 dose (nasal). Concomitant Therapy: Patient was not taking concomitant therapy. Event Details: On the evening of 12-Dec-2003, after receiving Flumist, the patient started to feel sick. During the night, she developed a fever of 103 degrees F., her body ached and she had nasal congestion. On 14-Dec-2003, her fever was 101 degrees F. On the morning of 15-Dec-2003, the patient no longer had a fever and she began to feel better. It is unknown if any treatment medications were taken. No additional information was available at the time of this report.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old male patient received BNT162b2 (BNT162B2), on 10May2022 at 18:00 as dose 4 (booster), single (Lot number: FM0173) at the age of 70 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Enlarged prostate" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Aug2022) Negative; (Aug2022) Negative; (Aug2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient received Antiviral as COVID-19 Treatment from 22Aug2022 to 26Aug2022 for treatment of COVID-19. Patient received other medications/products within 2 weeks of starting COVID-19 treatment was Tamsulosin 4 mg (Lot: HAD0555a). patient previously received a COVID-19 Vaccine. Five days after finishing the Paxlovid regimen, and twice testing negative, Ithe patient was tested positive again after experiencing some mild symptoms. Patient had no known allergies.
Complained of redness, swelling and pain at injection site. Began within 24 hours of injection. Also, complained of cramping and diarrhea with onset in 18 hours, post vax. This continues today (day 2).
Large hive grew over injection sight left deltoid had to be picked up at school and taken to Doctors Treated with strong antihistamine Mother has family history of vaccine reaction but in compliance with the law pediatrition agreed to separate and to space patient's shots and monitored him because patient recently had a DTP reaction school was informed by mother to watch for adverse reaction day after shot red mark at injection sight was size of 50 cent piece Nurse outlined called mom I would like confirmation you received this paper work on adverse reactions that my son had for (Tdap) (Menigalcocal) "some kind of documentation" for future
bronchitis; sore left arm; fever; sick; pink eye; This case was reported by a consumer via call center representative and described the occurrence of pinkeye in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2019, the patient received the 1st dose of Shingrix (intramuscular). In January 2020, between 1 and 3 months after receiving Shingrix, the patient experienced pinkeye. In February 2020, the patient experienced low grade fever and sickness. On an unknown date, the patient experienced bronchitis and pain in arm. On an unknown date, the outcome of the pinkeye, bronchitis, low grade fever, sickness and pain in arm were recovered/resolved.   It was unknown if the reporter considered the pinkeye, bronchitis, low grade fever, sickness and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left arm. Less than 3 months after vaccination, the patient experienced sore arm and bronchitis. The patient had a sore left arm for a day or so. The patient caught bronchitis due to her mother being sick and she was in and out of the hospital visiting her. In January 2020 and February 2020, the patient experienced pink eye. In the first week of February 2020 (between 2 and 4 months after vaccination), her husband came home with  all the symptoms of coronavirus from his work and she was sick with him for two weeks. She had a low grade fever and it resolved after a couple of weeks. She reported that she was sick all winter long. The reporter consented to follow up. This case has been linked to US2020053230 and US2020053232, reported by the same reporter.
Patient awoke the morning after her 1st COVID vaccination. Reported she slept well. Her arm was sore from COVID shot. She was up for approximately 20 min and had brushed her teeth and did her hair. She was going to get dressed for the day and states she got a sudden pounding headache and felt nauseous. She was on her way out to the kitchen to tell us she didn't feel good when she blacked out. She face planted, hitting her forehead on the hardwood floor witnessed by both parents. She was out for approximately 30 seconds. Her blood pressure was 90/60, HR 120, O2 on rm air was 98%. She has no previous history of syncope. After spell heart rate ran in the 100-110s for about 30 min and then normalized around 88-95. Was tired and sleepy for 2 hours after. (No post ictal sx to suggest seizure) Patient also received Tdap and meningococcal vaccine in other arm at the time of 1st Covid vaccination. The night of her COVID shot patient had normal appetite and activity level.
not yet had the 2nd dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in April 2023).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: not yet had the 2nd dose). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date- 08-NOV-2023 The patient not yet had the 2nd dose.  Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient did not consent to follow up.
Approx. 15:00 on 7/26/01, pt developed swelling of eyes, lips, nose and sneezing. Within 15 minutes, hives appeared on face, arms, feet and wheezing by auscultation. Symptoms occurred within 10 minutes of receiving injections. At 15:20, pt was treated with Benadryl 25mg and Decadron 10mg, IM. The follow-up states "back to normal" on 07/27/2001 by mom. No hives, no swelling, appetite good so may stop Benadryl.
Significant flu like symptoms that lasted for 36 hours from onset.  Included a fever of over 101, sweats, chills and uncontrollable shivering.  Had some numbness in fingers and toes.  These symptoms were actually more severe that when I had Covid 19. Taking Tylenol would help ease the symptoms, I did rotate in a dose of Ibuprofen on a 2 hour interval one time during the worst of the symptoms. After the 36 hour mark the symptoms faded and I returned to a normal state, although very drained and fatigued. The severity of the symptoms seem like they would be dangerous for someone who is not in good health.
This spontaneous report as received from an unspecified reporter referring to a 25 year old female patient. The patient's pertinent medical history, concurrent conditions and concomitant medications were not provided. On 20-JAN-2018, the patient was vaccinated with incorrect storage (wistar ra 27-3) M-M-R II lot # N020925, expiration date on 01-AUG-2019, for prophylaxis (strength, dose, route of administration and anatomical location were not reported). The vaccine was stored at 34.20°F during 0.17 hours. It was reported that vaccine was good when was administered.
Patient presents to the ED with abdominal pain, fatigue, worsening jaundice, anxiety, tremulousness and shortness of breath. Patient was also found to be COVID positive. She was admitted for management of acute metabolic encephalopathy, acute on chronic liver failure, hyponatremia, hypokalemia, large ascites, acute on chronic pancreatitis. She was discharged 16 days later in stable condition.
Left Achilles tendon rupture. No preexisting condition or antibiotics. No other possible cause. Patient was in good physical health and was not engaging in unusual activity. Incident required surgical repair and patient remains unable to work while rehabbing the repair.
24 hrs later - severe- headache, nausea, chills, aches - lasted about 6 hrs. No treatment
Sudden appearance of continuous vertigo. Worst when changing positions but doesn?t exclusively appear then. Seemed to lessen slightly towards the end of last night but is much worse this morning. Some light nausea.
I was administered my 3rd Pfizer shot which was a booster. The pharmacist at the pharmacy administered the shot. I was sick 5 days following bed ridden and then my left shoulder has had inflammation and locking up problems. It has been almost 2.5 months.
Swelling and discomfort in left armpit lymphomas. (Near chest cavity and at near arm)
This spontaneous report was received from a registered pharmacist refers to a 57 years old female patient with no drug reactions or allergies, who on 29-AUG-2012, was vaccinated subcutaneously with a dose of ZOSTAVAX (lot number 0566AE, Exp. Date: 01-APR-2013) (dose not reported). No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that on 29-AUG-2012, the same day that the ZOSTAVAX was administered there was a raised red rash three inches in diameter that developed around the injection site that was also warm to touch. No treatment was given for the experience. At the time of the report, the patient had not recovered. The patient sought medical attention by calling the pharmacist. The relatedness for there was a red raised rash three inches in diameter that was also warm to touch was unknown for ZOSTAVAX. Additional information has been requested.
Syringe malfunction upon administration with a significant fluid loss. Patient re-vaccinated on opposite arm. Pharmacy made aware.
Patient feel dizzy, light headedness, vision changes, observe peel, muscles relax. Did not loose consciousness during brief event, was alert and oriented there after. Escorted by nurse and family member to observation area. observed for 30mins.